143 related articles for article (PubMed ID: 4151686)
1. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
Noguchi Y; Nakao K; Kato H; Takagi K
Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
[No Abstract] [Full Text] [Related]
2. [Effects of beta receptor blocking agent, 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) on the circulatory system during intubation for general anesthesia].
Kim SY; Miyamoto K; Yoshikawa K
Masui; 1975 Aug; 24(8):780-6. PubMed ID: 240954
[No Abstract] [Full Text] [Related]
3. Cardiovascular beta-adrenergic receptor blocking activities of 1-(7-indenyloxy)-3-isopropyl-aminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
Kato H; Noguchi Y; Nakao K; Takagi K
Jpn J Pharmacol; 1974 Apr; 24(2):261-70. PubMed ID: 4152803
[No Abstract] [Full Text] [Related]
4. Electrophysiologically determined quinidine-like actions of a beta-adrenergic blocking agent, 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2).
Tatsuno H; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):197-207. PubMed ID: 9035
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
[No Abstract] [Full Text] [Related]
6. Beta receptor blocking and antiarrhythmic properties of tolamolol.
Bagwell EE; Custy J; Steen RG; Newman WH
J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
[No Abstract] [Full Text] [Related]
7. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
Caputi AP; Marmo E; Saini RK
Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
[No Abstract] [Full Text] [Related]
8. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
Zechel HJ
Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
[No Abstract] [Full Text] [Related]
9. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
Tachikawa S; Takenaka T
Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
[No Abstract] [Full Text] [Related]
10. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
[TBL] [Abstract][Full Text] [Related]
11. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
Mouillé P; Cheymol G
C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
[No Abstract] [Full Text] [Related]
12. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
Klempt HW; Bender F
Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
[No Abstract] [Full Text] [Related]
13. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
Reyes G; Ramírez T; Hong E
Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
[No Abstract] [Full Text] [Related]
14. [Membrane stabilizing actions of befunolol and indenolol, new beta-adrenergic receptor blocking drugs (author's transl)].
Sada H; Harada S; Kojima M; Ban T
Kokyu To Junkan; 1981 Nov; 29(11):1231-7. PubMed ID: 6121358
[No Abstract] [Full Text] [Related]
15. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
Prahl P; Prahl M
Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
[No Abstract] [Full Text] [Related]
16. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
[TBL] [Abstract][Full Text] [Related]
17. -adrenergic blocking and cardiovascular properties of a new compound, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2).
Tanenaka T; Tachikawa S
Arzneimittelforschung; 1972 Nov; 22(11):1864-9. PubMed ID: 4144713
[No Abstract] [Full Text] [Related]
18. New N-isopropyl and N-tert.-butyl-phenoxypropanolaminic derivatives having -adrenolytic, anti-arrhythmic and local anaesthetic activity.
Marmo E; Caputi AP; Saini RK
Arzneimittelforschung; 1972 Jul; 22(7):1109-17. PubMed ID: 4404342
[No Abstract] [Full Text] [Related]
19. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
Femmer K
Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
[No Abstract] [Full Text] [Related]
20. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Horii D; Kawada T; Takeda K; Imai S
Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
[No Abstract] [Full Text] [Related]
[Next] [New Search]